Paul F. GLIDDEN,Alison J. PILGRIM,Stephen R. HANSON
申请号：
US14670782
公开号：
US20160051552A1
申请日:
2015.03.27
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided.
